Patients who seek high-CBD formulations for chronic pain, anxiety or epilepsy now have access to Tilray 2:100 CBD oil, the highest concentration of CBD extract currently available in the legal Canadian medical cannabis marketplace.
2:100 contains a target concentration of 2 mg/mL THC and 100 mg/mL CBD, and a target content of 80 mg THC and 4,000 mg CBD per bottle. Tilray 2:100 CBD oil is a broad-spectrum cannabis extract, produced in our GMP-certified facility to a standard that exceeds quality regulations set by Health Canada.
It is now available to all Tilray patients with an approved medical document.
This high-CBD extract has the same target concentration of THC and CBD as the study drug used in the clinical trial on pediatric epilepsy conducted at the Hospital for Sick Children (SickKids) in Toro